scispace - formally typeset
C

Christoph Terborg

Researcher at University of Jena

Publications -  37
Citations -  1517

Christoph Terborg is an academic researcher from University of Jena. The author has contributed to research in topics: Cerebral blood flow & Middle cerebral artery. The author has an hindex of 16, co-authored 37 publications receiving 1392 citations. Previous affiliations of Christoph Terborg include Schiller International University.

Papers
More filters
Journal ArticleDOI

Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.

TL;DR: Among patients with OAC-associated ICH, reversal of anticoagulation reversal and blood pressure (BP) with hematoma enlargement and resumption of OAC therapy was associated with lower risk of ischemic events, and these findings require replication and assessment in prospective studies.
Journal ArticleDOI

Reduced Vasomotor Reactivity in Cerebral Microangiopathy A Study With Near-Infrared Spectroscopy and Transcranial Doppler Sonography

TL;DR: VMR is reduced in patients with cerebral microangiopathy and can be noninvasively assessed in basal arteries and brain parenchyma (with NIRS) and reduction of CO(2)-induced VMR, as measured by NIRs and TCD, may indicate the severity of microangipathy.
Journal ArticleDOI

Dysfunction of vasomotor reactivity in severe sepsis and septic shock

TL;DR: In the advent of a disturbed cerebral autoregulation, critical drops in blood pressure during sepsis are transferred directly into the vascular bed, leading to cerebral hypoperfusion, which might contribute to the pathogenesis of septic encephalopathy.
Journal Article

Bedside assessment of cerebral perfusion reductions in patients with acute ischaemic stroke by near-infrared spectroscopy and indocyanine green

TL;DR: Measurement of interhemispheric differences in ICG kinetics by NIRS detects perfusion reductions in patients with acute middle cerebral artery infarction, and is rapid, repeatable, without major side effects, and avoids transportation of critically ill patients.
Journal ArticleDOI

Early disruption of the blood-brain barrier after thrombolytic therapy predicts hemorrhage in patients with acute stroke.

TL;DR: Early parenchymal enhancement after intravenous tissue plasminogen activator is significantly associated with subsequent SICH and could therefore become a useful imaging sign for the rapid initiation of preventive strategies in the future.